Ra Medical Stock Analysis

RMED -  USA Stock  

USD 5.22  0.01  0.19%

The latest surge in Ra Medical Systems short term price appreciation created some momentum for shareholders as it was traded today as low as 5.13 and as high as 5.6 per share. The company executives have successfully maneuvered the company at convenient times to take advantage of all market conditions in May. The stock standard deviation of daily returns for 90 days investing horizon is currently 12.86. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Ra Medical Systems partners.
Additionally, take a look at Your Equity Center.

Search Stock Analysis 

The Ra Medical stock analysis report makes it easy to digest most publicly released information about Ra Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Ra Medical stock analysis module also helps to analyze the Ra Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Ra Medical Stock Analysis Notes

About 19.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.79. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ra Medical Systems recorded a loss per share of 21.22. The entity had not issued any dividends in recent years. The firm had 1-25 split on the 17th of November 2020. Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California. Ra Medical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 85 people. To find out more about Ra Medical Systems contact the company at 760 804 1648 or learn more at http://www.ramed.com.

Ra Medical Systems Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ra Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ra Medical Systems or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ra Medical Systems has very high historical volatility over the last 90 days
Ra Medical Systems has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 4.41 M. Net Loss for the year was (36.05 M) with loss before overhead, payroll, taxes, and interest of (1.08 M).
Ra Medical Systems currently holds about 23.91 M in cash with (28.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 19.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.equities.com: Ra Medical Systems Inc falls -7.4340 percent for June 15 - Equities.com

Ra Medical Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ra Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ra Medical Systems backward and forwards among themselves. Ra Medical's institutional investor refers to the entity that pools money to purchase Ra Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Royce Associates LpCommon Shares317.6 K1.5 M
Renaissance Technologies LlcCommon Shares155.5 K725 K
Dowling Yahnke LlcCommon Shares68.4 K319 K
Gsa Capital Partners LlpCommon Shares49.5 K231 K
Vanguard Group IncCommon Shares38.7 K180 K
Bridgeway Capital Management LlcCommon Shares33 K154 K
Virtu Financial LlcCommon Shares29.4 K137 K
Note, although Ra Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ra Medical Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 16.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ra Medical's market, we take the total number of its shares issued and multiply it by Ra Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (58.14) % which means that it has lost $58.14 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (132.77) %, meaning that it created substantial loss on money invested by shareholders. Ra Medical management efficiency ratios could be used to measure how well ra medical systems manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 19th of June, Ra Medical owns the market risk adjusted performance of (0.31), and Standard Deviation of 12.7. In respect to fundamental indicators, the technical analysis model allows you to check possible technical drivers of Ra Medical Systems, as well as the relationship between them. Strictly speaking, you can use this information to find out if the company will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Ra Medical, which can be compared to its peers in the sector. Please check Ra Medical Systems jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Ra Medical Systems is priced fairly, providing market reflects its prevailing price of 5.22 per share. Given that Ra Medical Systems has jensen alpha of 0.3827, we recommend you to check out Ra Medical's latest market performance to make sure the company can sustain itself in the future.

Ra Medical Systems Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Triangular Moving Average shows Ra Medical double smoothed mean price over a specified number of previous prices (i.e., averaged twice). View also all equity analysis or get more info about triangular moving average overlap studies indicator.

Ra Medical Systems Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ra Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ra Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ra Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ra Medical Predictive Daily Indicators

Ra Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ra Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ra Medical Forecast Models

Ra Medical time-series forecasting models is one of many Ra Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ra Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Ra Medical Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ra Medical stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ra Medical shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Ra Medical. By using and applying Ra Medical Stock analysis, traders can create a robust methodology for identifying Ra Medical entry and exit points for their positions.
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California. Ra Medical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 85 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Ra Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Piotroski F Score Now


Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module
Additionally, take a look at Your Equity Center. Note that the Ra Medical Systems information on this page should be used as a complementary analysis to other Ra Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Ra Medical Stock analysis

When running Ra Medical Systems price analysis, check to measure Ra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ra Medical is operating at the current time. Most of Ra Medical's value examination focuses on studying past and present price action to predict the probability of Ra Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Ra Medical's price. Additionally, you may evaluate how the addition of Ra Medical to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
The market value of Ra Medical Systems is measured differently than its book value, which is the value of Ra Medical that is recorded on the company's balance sheet. Investors also form their own opinion of Ra Medical's value that differs from its market value or its book value, called intrinsic value, which is Ra Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ra Medical's market value can be influenced by many factors that don't directly affect Ra Medical Systems underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ra Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Ra Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ra Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.